Cargando…

Hereditary breast cancer – a spectrum of pathogenic mutations and unknown variants of BRCA1 and BRCA2 genes in the Czech Republic: efficiency of testing and clinical follow-up

Detalles Bibliográficos
Autores principales:	Foretova, L, Lukesova, M, Vasickova, P, Navratilova, M, Pavlu, H, Kuklova, J, Urbankova, V, Hanouskova, D, Dvorackova, B, Machackova, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233514/ http://dx.doi.org/10.1186/bcr1093

Ejemplares similares

High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic
por: Vasickova, Petra, et al.
Publicado: (2007)

Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer
por: Machackova, Eva, et al.
Publicado: (2008)

Genetic and Preventive Services for Hereditary Breast and Ovarian Cancer in the Czech Republic
por: Foretova, Lenka, et al.
Publicado: (2006)

The Czech Republic: Genetic Counseling in High-Risk Breast/Ovarian Cancer Families
por: Foretova, L., et al.
Publicado: (1999)

Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic
por: Zimovjanova, Martina, et al.
Publicado: (2023)

Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families
por: NOVAKOVIĆ, SRDJAN, et al.
Publicado: (2012)

Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden
por: Wendt, Camilla, et al.
Publicado: (2015)

NINE YEAR CHANGES IN PREVALENCE OF COGNITIVE IMPAIRMENT IN THE CZECH REPUBLIC
por: Seblova, Dominika, et al.
Publicado: (2019)

Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
por: Sukumar, Jasmine, et al.
Publicado: (2021)

Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2
por: Samuel, David, et al.
Publicado: (2022)

Hepatitis E – epidemiology and clinical course in the largest cohort in the Czech Republic
por: Mihalčin, Matúš, et al.
Publicado: (2022)

Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
por: Kim, Joo Heung, et al.
Publicado: (2021)

Age and Geographical Distribution in Families with BRCA1/BRCA2 Mutations in the Slovak Republic
por: Ciernikova, Sona, et al.
Publicado: (2006)

Causes of admission, length of stay and outcomes for common kestrels in rehabilitation centres in the Czech Republic
por: Lukesova, Gabriela, et al.
Publicado: (2021)

Preliminary Study of Sars-Cov-2 Occurrence in Wastewater in the Czech Republic
por: Mlejnkova, Hana, et al.
Publicado: (2020)

Mutation Analysis of the BRCA1 and BRCA2 Genes in the Belgian Patient Population and Identification of a Belgian Founder Mutation BRCA1 IVS5+3A>G
por: Claes, Kathleen, et al.
Publicado: (1999)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
por: Ewald, Ingrid Petroni, et al.
Publicado: (2016)

Detection and Phylogenetic Characterization of Human Hepatitis E Virus Strains, Czech Republic
por: Vasickova, Petra, et al.
Publicado: (2011)

The Clinical Significance of Unknown Sequence Variants in BRCA Genes
por: Calò, Valentina, et al.
Publicado: (2010)

Clinical significance of variants of unknown significances in BRCA genes
por: Choi, Min Chul
Publicado: (2019)

Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer
por: Buleje, Jose, et al.
Publicado: (2017)

Causes of admission and outcomes of brown hare (Lepus europaeus) leverets at wildlife rescue centres in the Czech Republic
por: Lukesova, Gabriela, et al.
Publicado: (2022)

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
por: Li, Shuai, et al.
Publicado: (2022)

Author Correction: Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
por: Kim, Joo Heung, et al.
Publicado: (2023)

Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium
por: Kast, Karin, et al.
Publicado: (2023)

Hereditary Susceptibility to Breast Cancer: Significance of Age of Onset in Family History and Contribution of BRCA1 and BRCA2
por: Frank, Thomas S., et al.
Publicado: (1999)

Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing
por: Kang, Hyunseok P., et al.
Publicado: (2016)

Case report: Analysis of BRCA1 and BRCA2 gene mutations in a hereditary ovarian cancer family
por: Liao, Ying, et al.
Publicado: (2020)

Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer
por: Garber, Haven R., et al.
Publicado: (2022)

Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants
por: Momozawa, Yukihide, et al.
Publicado: (2022)

Mutational spectrum in breast cancer associated BRCA1 and BRCA2 genes in Colombia
por: Briceño-Balcázar, Ignacio, et al.
Publicado: (2017)

Adolescent Health Literacy and Neighbourhood Features: HBSC Findings from Czech Republic, Poland, and Slovakia
por: Kleszczewska, Dorota, et al.
Publicado: (2021)

BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers
por: Osman, K., et al.
Publicado: (2023)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas
por: Kamieniak, M M, et al.
Publicado: (2013)

Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)
por: Blay, Pilar, et al.
Publicado: (2013)

Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes
por: Toss, Angela, et al.
Publicado: (2015)

Predicting Ovarian/Breast Cancer Pathogenic Risks of Human BRCA1 Gene Variants of Unknown Significance
por: Lin, Hui-Heng, et al.
Publicado: (2021)

Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes
por: Soukupova, Jana, et al.
Publicado: (2018)

Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites
por: Digennaro, M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1pks3166imfue6p1cot88ucc7g